PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Effective at the opening on Tuesday, January 20, 2026, the shares of the Company will commence trading on the TSX Venture Exchange on a consolidated basis. The name and stock symbol of the Company ...